These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26070756)

  • 1. Neurologic Complications of Psychomotor Stimulant Abuse.
    Sanchez-Ramos J
    Int Rev Neurobiol; 2015; 120():131-60. PubMed ID: 26070756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychostimulants.
    Sanchez-Ramos JR
    Neurol Clin; 1993 Aug; 11(3):535-53. PubMed ID: 8104314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
    Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of stimulant drugs in a community sample of drug users.
    Williamson S; Gossop M; Powis B; Griffiths P; Fountain J; Strang J
    Drug Alcohol Depend; 1997 Mar; 44(2-3):87-94. PubMed ID: 9088780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS stimulants and the look-alike drugs.
    Lake CR; Quirk RS
    Psychiatr Clin North Am; 1984 Dec; 7(4):689-701. PubMed ID: 6151645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential adverse effects of amphetamine treatment on brain and behavior: a review.
    Berman SM; Kuczenski R; McCracken JT; London ED
    Mol Psychiatry; 2009 Feb; 14(2):123-42. PubMed ID: 18698321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
    National Toxicology Program
    NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity and abuse of prescribed stimulants.
    Spier SA
    Int J Psychiatry Med; 1995; 25(1):69-79. PubMed ID: 7649719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant medication for ADHD in opioid maintenance treatment.
    Abel KF; Bramness JG; Martinsen EW
    J Dual Diagn; 2014; 10(1):32-8. PubMed ID: 25392060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    Camacho A; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.
    Faraone SV; Biederman J; Wilens TE; Adamson J
    Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation.
    Parrott AC
    Hum Psychopharmacol; 2015 Jul; 30(4):213-24. PubMed ID: 26216554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic manifestations of chronic methamphetamine abuse.
    Rusyniak DE
    Neurol Clin; 2011 Aug; 29(3):641-55. PubMed ID: 21803215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine abuse.
    Winslow BT; Voorhees KI; Pehl KA
    Am Fam Physician; 2007 Oct; 76(8):1169-74. PubMed ID: 17990840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.